Pharmafile Logo

B2B sales

- PMLiVE

CureVac reveals early data for mRNA-based COVID-19 vaccine candidate

German biotech says vaccine demonstrated an immune response in phase 1/2

- PMLiVE

Regeneron halts enrolment of severely ill patients in COVID-19 antibody trial

Trial modified based on recommendations from independent data monitoring committee

- PMLiVE

On our best behaviour

Why driving behaviour change is the next big focus for pharma companies in chronic diseases

- PMLiVE

How does nature influence wellbeing and refocus the mind?

Time is the 21st century's most precious commodity – we all live in a world where rushing around seems more normal than having a relaxing coffee break

Life Healthcare Communications

- PMLiVE

Praising the medical team for an excellent launch

Finding great medics to work on a launch team is a tough challenge, but definitely worth the effort

Article

How will COVID-19 affect uptake of vaccinations against other diseases?

Inizio

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.

Impetus Digital

Podcast

Living With Chronic Illness (Series one)

Inizio

- PMLiVE

How to make an impact at a virtual congress

As hard as congress organisers try, replicating the congress experience on a virtual platform is difficult. Rather than trying to replicate the in-person congress experience, the industry has a real...

Blue Latitude Health

Webcast

China: How pharma can maximize success in this rapidly changing emerging market

Inizio

- PMLiVE

The Unknown Unknowns

Patient insights are fundamental to ensuring we understand the reality of living with a condition. We need to consciously  challenge our approach and ensure we are unearthing authentic patient insights that...

Bedrock Healthcare Communications

- PMLiVE

Getting the balance right

The new normal for UK healthcare comms

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links